Allogene Therapeutics Reports Third Quarter 2019 Financial Results

Go back to Allogene Therapeutics Reports Third Quarter 2019 Financial Results
(NASDAQ: ALLO) Delayed: 2.15 +0.12 (5.91%)
Previous Close $2.03    52 Week High
Open $2.08    52 Week Low
Day High $2.16    P/E N/A 
Day Low $2.08    EPS
Volume 4,312,898